Report Sellers has added a new market research report “Cancer Immunotherapy – Global Market Outlook (2017-23)” to its offerings.
According to Report, Global Cancer Immunotherapy Market is estimated at $62.57 billion in 2016 and is expected to reach $160.24 billion by 2023 growing at a CAGR of 14.3% from 2016 to 2023. Rapid increase in cases of cancer across the globe, technical advancement in treatment therapies, smoking and excessive consumption of alcohol which causes cancer are some of the factors fueling the market growth. High cost for the treatment and lack of awareness are the restraints hampering the market. On the other hand rise in clinical trials against different cancers in immunotherapy and elevated expansion prediction in developing countries are some opportunities for the market over the forecast period.
Based on product, the monoclonal antibodies are made by single clone of cells or cell line and are comprised of identical antibody molecules. The factors such as growing occurrence of cancer and other chronic diseases, rising awareness among patients and rising requirement for personalized medicine are favoring this products segment.
In terms of geography, North America captured largest share owing to high mortality rate among cancer patients and government initiative programs to create awareness among the people. Asia Pacific region is expected to be fastest growing during forecast period.
Some of the key players in the market include Bristol-Myers Squibb, F. Hoffmann-LA Roche Ltd, GlaxoSmithKline, Pfizer, Eli Lilly and Company, Janssen Global Services, LLC (Johnson and Johnson), Novartis, Amgen Inc., Biovest International Inc, Ablynx NV, Genentech Inc, Bellicum Pharmaceuticals Inc, Bayer AG, Oxford BioTherapeutics Ltd., Merck, Sydys Corporation, Dendreon, Xencor, Daiichi Sankyo and TG Therapeutics.
Browse through the complete description and in-depth TOC on “Global Cancer Immunotherapy Market”
What does the Report Offers
Market share assessments for the regional and country level segments
Market share analysis of the top industry players
Strategic recommendations for the new entrants
Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Global Cancer Immunotherapy Market has been segmented by product types covered, cancer types covered, end users covered and regions covered
Product Types Covered:
Immune Checkpoint Inhibitors
o Cytotoxic T-Lymphocyte-Associated Protein-4 (CTLA-4)
o Programmed Death 1 (PD-1) and Programmed Death Ligand 1 (PD-L1)
Cancer Monoclonal Antibodies
o Conjugated Monoclonal Antibodies
o Bispecific Monoclonal Antibodies
o Naked Monoclonal Antibodies
o Oncolytic Virus
o Interleukins (IL)
o Interferons (IFN)
o Prophylactic Vaccines
o Therapeutic Vaccines
o Chimeric Antigen Receptor (CAR) T Cell Therapy
o Dendritic Cells
Cancer Types Covered:
Head & Neck Cancer
Other Cancer Types
End Users Covered:
Other End Users
Rest of Europe
Rest of Asia Pacific
Rest of South America
Middle East & Africa
Rest of Middle East & Africa
We have a large number of reports in Healthcare Industry which can be accessed in the following link: https://www.reportsellers.com/category/healthcare-market-research-report
About Report Sellers
Report Sellers is a premium market research service provider offering market reports in varied sectors. We have a team of experienced analysts and publishers who continuously track the latest trends in different industries. Report Sellers is a brand of global repute and offers the best suited research services to its clients globally in the most satisfying manner. We have a strong network of industry experts who have successfully delivered complex research assignments in niche and top markets.
For more information, contact